THURSDAY, Feb. 9, 2023 (HealthDay News) — A single injection of an experimental biologic drug may cut in half your risk of hospitalization from COVID-19 infection, new clinical trial results show. Pegylated lambda interferon (PEG-lambda) proved effective against all COVID-19 variants encountered in this international study, including Omicron, according toContinue Reading

WEDNESDAY, Jan. 25, 2023 (HealthDay News) — The American Heart Association has issued a new scientific statement on pulmonary embolism (PE), a sometimes fatal condition in which a blood clot travels to the lungs. The American Heart Association (AHA) statement suggests surgery be considered for more people with high-risk PE.Continue Reading